Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transgender Cohort Study of Gender Affirmation and HIV-related Health

NCT03595956 is registered in ClinicalTrials.gov with Fenway Community Health as lead sponsor.

NCT NCT03595956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03595956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transgender Cohort Study of Gender Affirmation and HIV-related Health
Lead sponsor
Fenway Community Health
Phase
Observational
Overall status
Unknown status
Start date
February 11, 2019
Completion date
December 31, 2021
Enrollment
4,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, anxiety, gender dysphoria, gender identity, hiv/aids, sti, transsexualism